Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Caffeine citrate

EU orphan designation number: EU/3/14/1261   
Active ingredient: Caffeine citrate
Indication: Prevention of bronchopulmonary dysplasia
Sponsor: Viridian Pharma Ltd
Yew Tree House, Hendrew Lane, Llandevaud, Newport, Gwent, NP18 2AB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/04/2014 Orphan designation EMA/OD/161/13 (2014)2649 of 11/04/2014